- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02942667
Magnetic Resonance Imaging of Human Biometrics (MRI HB)
February 6, 2018 updated by: Medtronic Cardiac Rhythm and Heart Failure
The primary objective is to collect high quality MRI data (un-processed or processed) from participating subjects for Medtronic research purposes.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study will enroll up to 30 subjects at up to 5 study sites in the US.
Description
Inclusion Criteria:
- Subject is at least 18 years of age
- Subject is willing and able to undergo study requirements
Exclusion Criteria:
- Subject has a medical condition that precludes the subject from participation
- Subject has any magnetizable foreign object (e.g. jewelry) which cannot be removed for the duration of the study
- Subject is claustrophobic
- Subject is unable to stand without assistance
- Subject requires sedation for MRI scans
Subject is implanted with non-Magnetic Resonance conditional or other medical device:
- Non-MRI conditional pacemaker, Implantable Cardiac Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT), or an implantable hemodynamic monitor
- Metal clips (i.e. brain aneurysm clip)
- Artificial heart valve
- Implanted neural stimulator
- Gastric capsule camera
- Swan Ganz catheter
- Stent
- Inferior Vena Cava (IVC) filter
- Orthopedic implant
- Eye prosthesis
- Vascular access port
- Penile prosthesis
- Intrauterine device
- Subject has a cochlear implant, middle ear prosthesis, or has had ear surgery
- Subject has ocular foreign bodies (i.e. metal shavings)
- Subject has any type of device held in place by a magnet (i.e. dentures)
- Subject has an insulin pump
- Subject has metal shrapnel
- Subject is pregnant or lactating
- Subject has magnetizable implant
- Subject requires legally authorized representative to sign Patient Informed Consent (PIC)/ Informed Consent (IC) form
- Subject has other contraindication for an MRI scan as defined by the study site
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Subjects undergoing high quality MRI Scans
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Collect High Quality MRI Data
Time Frame: Approximately 6 Weeks
|
Approximately 6 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2016
Primary Completion (Actual)
December 6, 2017
Study Completion (Actual)
February 2, 2018
Study Registration Dates
First Submitted
September 30, 2016
First Submitted That Met QC Criteria
October 21, 2016
First Posted (Estimate)
October 24, 2016
Study Record Updates
Last Update Posted (Actual)
February 7, 2018
Last Update Submitted That Met QC Criteria
February 6, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- MRI HB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Volunteers
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
University Hospital, Clermont-FerrandInstitut de Médecine du Travail; UMR CNRS 6024, LaPSCoRecruiting
-
McMaster UniversityOntario Ministry of Health and Long Term Care; Canadian Red Cross; David BraleyCompleted
-
Göteborg UniversityRecruiting